查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1974098

快速口腔液篩檢設備市場：依產品類型、技術、應用、最終用戶和通路分類－2026-2032年全球預測

Rapid Oral Fluid Screening Devices Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，快速口腔液篩檢設備市場價值將達到 118.3 億美元，到 2026 年將成長至 131.7 億美元，到 2032 年將達到 266.9 億美元，複合年成長率為 12.32%。

主要市場統計數據
基準年 2025 118.3億美元
預計年份：2026年 131.7億美元
預測年份 2032 266.9億美元
複合年成長率 (%) 12.32%

本次演講對快速口腔液篩檢設備在臨床環境、職場和法醫學環境中的不斷發展的作用進行了簡明扼要而又權威的概述。

快速口腔液篩檢設備已從最初的局部照護現場工具發展成為臨床、職業和法醫學領域不可或缺的設備。這些設備透過微創採樣即可取得近期藥物使用情況的截面數據，與傳統的生物樣本相比，能夠更快地進行分診，並簡化大規模篩檢的物流。隨著臨床工作流程、職場合規計畫和以地區為基礎檢測舉措對速度、便利性和降低生物危害風險的重視程度不斷提高，口腔液已成為一種實用的檢體，能夠在不影響程序嚴謹性的前提下，支持分散式檢查。

技術進步、監管澄清和數位整合正在重新定義口腔內液體篩檢的採購重點和部署模式。

在技​​術進步、法規監管和用戶期望的共同推動下，快速口腔液篩檢領域經歷了多次變革。免疫檢測設計和層析法檢測技術的進步提高了分析性能，同時縮短了結果時間並減少了人為誤差。這些技術進步與模組化、多分析物檢測模式的轉變相輔相成，使得在不影響工作流程簡便性的前提下，能夠檢測多種物質。因此，以往完全依賴集中式檢查室檢測的機構現在正在評估照護現場和接近專利期的檢測方案，用於初步篩檢和風險分層。

貿易政策調整和供應鏈關稅變化迫使製造商和買家重新評估其採購、物流和合約保護措施。

近期貿易政策措施引發了人們對診斷設備（包括口腔液篩檢產品）全球採購和供應鏈韌性的新考量。關稅措施及相關合規要求使依賴跨境零件分銷的製造商、經銷商和醫療機構的採購流程變得更加複雜。從國際市場採購試劑、薄膜和電子元件的製造商正在評估替代供應商、近岸外包方案和庫存策略，以減輕關稅調整和行政延誤造成的營運摩擦。

將產品類型、分析技術、應用領域、最終用戶需求和分銷管道與商業策略連結起來的綜合細分洞察。

細分市場分析揭示了性能特徵與商業策略的交集，有助於產品開發和市場策略的發展。根據產品類型，開發人員需要在多面板檢測設備的廣泛覆蓋範圍和單面板檢測試劑盒的針對性簡易性之間取得平衡，以滿足不同應用情境的優先順序和處理能力需求。從技術角度來看，設備開發藍圖越來越反映分析穩健性和使用者友善性之間的權衡，因為層析法和免疫檢測的選擇會影響靈敏度、單次檢測成本和結果解讀的便利性。不同應用的需求差異顯著。臨床診斷需要嚴格的文件記錄並與患者病歷整合，而家庭檢測則更注重直覺的檢體收集和清晰的操作說明。執法機關強調證據管理鍊和即時證據價值，而職場檢測則需要符合合規計畫的可擴展工作流程。

區域部署模式受到全球主要市場法規、採購慣例和基礎設施考量多樣性的影響。

區域環境，包括法規結構、採購慣例和醫療基礎設施，對口腔液篩檢設備的部署和支援方式有顯著影響。在美洲，成熟的臨床和職業檢測計畫推動了對兼具性能和快速處理能力的設備的需求，相關人員傾向於優先考慮與現有確認實驗室工作流程的兼容性。在歐洲、中東和非洲，不同的管理體制和基礎設施能力導致了不同的部署模式。一些市場優先考慮符合當地標準和互通性，而其他市場則採用基於可及性和成本的解決方案。在亞太地區，快速的都市化、基層醫療網路的擴張以及對分散式檢查的重視，為可在診所和偏遠地區部署的簡化、穩健的設備創造了機會。

我們的競爭優勢源自於我們的測試效能、檢驗資料、廣泛的分銷網路和售後服務系統。

競爭格局受多種因素影響，包括技術差異化、法規遵循和分銷網路擴張。主要企業正致力於最佳化檢測方法、以使用者為中心的儀器設計以及全面的檢驗方案，以滿足臨床、職業和法醫學領域客戶的多元化需求。與檢測實​​驗室、經銷商和觀察機構建立策略合作夥伴關係，有助於在實際環境中進行效能演示，並促進機構採購。此外，那些透過數位化能力、客戶培訓計劃和完善的上市後監控來完善產品系列的企業，不僅在價格上，而且在整體價值上也脫穎而出。

為製造商和經銷商提供可操作且優先的行動方案，以增強產品適應性、供應彈性、合規應對力和客戶價值。

產業領導者應推動協作，使產品藍圖與營運實際情況和相關人員的期望保持一致。首先，應優先考慮模組化產品架構，在單一平台上支援多面板和單面板配置，從而實現針對不同終端用戶的快速客製化，避免重複增加製造複雜性。其次，應投資開發針對臨床、法醫學和職業應用情境的完善的檢驗和文件包，以簡化採購流程並支援合規性。第三，應透過關鍵投入品來源多元化、認證二級生產基地以及建立緩衝庫存政策，增強供應鏈韌性並減輕貿易中斷的影響。

我們透過透明且可重複的調查方法得出策略結論，該方法結合了相關人員訪談、同儕審查證據、監管指導和情境分析。

本研究整合了一手和二手訊息，建構了一個嚴謹且可重複的快速口腔液篩檢現狀圖景。一手資訊收集包括對設備開發人員、臨床實驗室經理、職業健康經理和執法機關採購人員進行結構化訪談，以直接了解他們對性能優先事項、採購障礙和實施經驗的看法。二級資訊來源包括關於檢體可靠性和檢測性能的同行評審文獻、監管指導文件、技術白皮書以及公開的產品檢驗摘要，以對各項聲明進行三角驗證，確保分析聲明基於檢驗的證據。

將技術能力與操作要求聯繫起來的全面分析，強調了永續實施所必需的綜合方法。

快速口腔液篩檢設備在臨床需求、操作實用性和監管要求三者之間佔據策略性地位。其吸引力在於能夠提供及時、微創的篩檢，從而支持在各種情況下做出即時決策。然而，成功推廣應用不僅需要提升分析效能，還需要在檢驗方法、供應鏈設計、數位化互通性和客戶支援等方面實現全面協調。採用整合式方法，結合可靠的證據產生、本地市場適應性和穩健的物流系統，能夠更好地將設備的功能轉化為永續的臨床和營運價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：快速口腔液篩檢設備市場：依產品類型分類

  • 多面板
  • 單面板

第9章：快速口腔液篩檢設備市場：依技術分類

  • 層析法
  • 免疫檢測

第10章：快速口腔液篩檢設備市場：依應用領域分類

  • 臨床診斷
  • 家庭測試
  • 對於執法機關
  • 職場檢查

第11章：快速口腔液篩檢設備市場：依最終用戶分類

  • 專業藥物檢測中心
  • 診斷檢查室
  • 醫院和診所

第12章：快速口腔液篩檢設備市場：依通路分類

  • 直銷
  • 批發商
  • 線上銷售

第13章：快速口腔液篩檢設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 快速口腔液篩檢設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：快速口腔液篩檢設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國快速口腔液篩檢設備市場

第17章：中國快速口腔液篩檢設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Chembio Diagnostic Systems, Inc.
  • Dragerwerk AG & Co. KGaA
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Roche Diagnostics GmbH
  • Securetec Detection Systems AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5D340F440B7E

The Rapid Oral Fluid Screening Devices Market was valued at USD 11.83 billion in 2025 and is projected to grow to USD 13.17 billion in 2026, with a CAGR of 12.32%, reaching USD 26.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.83 billion
Estimated Year [2026] USD 13.17 billion
Forecast Year [2032] USD 26.69 billion
CAGR (%) 12.32%

A concise yet authoritative orientation to the evolving role of rapid oral fluid screening devices across clinical, workplace, and forensic settings

Rapid oral fluid screening devices have evolved from niche point-of-care tools to essential instruments across clinical, occupational, and forensic environments. These devices capture a snapshot of recent substance use using minimally invasive sampling, enabling faster triage and larger-scale screening with simplified logistics compared with traditional biological matrices. As clinical workflows, workplace compliance programs, and community-based testing initiatives continue to prioritize speed, convenience, and reduced biohazard risk, oral fluid has emerged as a pragmatic specimen that supports decentralized testing without compromising procedural rigor.

Technological refinements, regulatory clarifications, and the maturation of distribution networks have collectively expanded the contexts in which oral fluid devices are considered viable. Concurrently, end users are demonstrating greater acceptance of point-of-collection screening for immediate decision support, while laboratory confirmation remains the backbone for definitive adjudication. Across these environments, manufacturers are balancing sensitivity and specificity improvements with usability criteria such as clear visual readouts, simplified sample collection, and integration into existing record-keeping systems. This introduction sets the stage for a focused examination of the transformative factors reshaping adoption pathways, competitive positioning, and stakeholder expectations.

How technical advances, regulatory clarity, and digital integration are redefining procurement priorities and deployment models for oral fluid screening

The landscape for rapid oral fluid screening has undergone several transformative shifts driven by technology, regulation, and user expectations. Advances in immunoassay design and chromatography-based readouts have improved analytical performance while reducing time-to-result and user error. These technical gains are complemented by a transition toward modular, multi-analyte formats that enable broader substance panels without sacrificing workflow simplicity. As a result, organizations that once relied solely on centralized laboratory testing now evaluate point-of-care and near-patient options for initial screening and risk stratification.

In regulatory arenas, clearer guidance on specimen integrity, chain-of-custody protocols, and device validation has increased confidence among procurement decision-makers. This regulatory maturation is influencing procurement cycles and enabling wider institutional uptake. In addition, digital enablement-ranging from smartphone-assisted read interpretation to cloud-based result logging-has extended device utility by connecting screening events to clinical or compliance records and supporting remote oversight. Taken together, these shifts are redefining procurement priorities, highlighting interoperability and traceability as competitive differentiators, and compelling stakeholders to rethink where and how oral fluid screening is deployed.

Trade policy adjustments and tariff-driven supply chain shifts prompting manufacturers and buyers to re-evaluate sourcing, logistics, and contractual protections

Recent trade policy actions have introduced new considerations for global sourcing and supply chain resiliency related to diagnostic devices, including oral fluid screening products. Tariff measures and associated compliance requirements have raised procurement complexity for manufacturers, distributors, and health systems that rely on cross-border component flows. Manufacturers that source reagents, membranes, or electronic components internationally are evaluating alternative suppliers, nearshoring options, and inventory strategies to mitigate the operational friction created by duty adjustments and administrative delays.

These dynamics have implications for cost structures, lead times, and supplier selection criteria. Procurement and operations teams are increasingly prioritizing supplier transparency, contractual protections, and multi-sourcing strategies to preserve continuity in device availability and validation activities. For companies that manufacture domestically, a comparative advantage may emerge in lead time and predictability, whereas exporters face new documentation burdens and potential delays at customs. The net effect is heightened attention to supply chain mapping, scenario planning, and cost-to-serve analyses that inform both pricing strategy and customer communications. Stakeholders who proactively adapt sourcing and logistics frameworks will be better positioned to preserve service levels and maintain trust with clinical and institutional customers.

Integrated segmentation insights tying product type, analytical technology, application context, end-user demands, and distribution channels to commercial strategy

Segmentation reveals where performance attributes and commercial strategies intersect to shape product development and go-to-market approaches. Based on product type, developers balance the broad coverage of multi-panel devices with the targeted simplicity of single-panel kits to address different use-case priorities and throughput requirements. Based on technology, choices between chromatography and immunoassay influence sensitivity profiles, cost per test, and ease of interpretation, so device roadmaps increasingly reflect the tradeoffs between analytical robustness and user simplicity. Based on application, requirements vary substantially: clinical diagnostics demand rigorous documentation and linkage to patient records, home testing prioritizes intuitive collection and clear instructions, law enforcement emphasizes chain-of-custody and immediate evidentiary value, while workplace testing requires scalable workflows that align with compliance programs.

Based on end user, the procurement and validation pathways differ; dedicated drug testing centers focus on throughput and confirmatory integration, diagnostic laboratories emphasize analytical comparability and result traceability, and hospitals and clinics require compatibility with clinical workflows and electronic health record systems. Based on distribution channel, strategies diverge between direct sales that enable bespoke customer support, distributors that provide reach into established networks, and online sales that drive convenience and decentralized ordering. Understanding these segmentation elements in combination provides a nuanced view of product-market fit, channel economics, and the service expectations that will influence adoption trajectories across settings.

Regional adoption patterns driven by regulatory diversity, procurement norms, and infrastructure considerations across major global markets

Regional conditions, including regulatory frameworks, procurement practices, and healthcare infrastructure, materially influence how oral fluid screening devices are adopted and supported. In the Americas, a mature combination of clinical and occupational testing programs creates demand for devices that balance performance with rapid throughput, and stakeholders often emphasize alignment with established confirmatory laboratory workflows. In Europe, Middle East & Africa, diverse regulatory regimes and varying infrastructure capabilities lead to differentiated adoption patterns; some markets prioritize conformity with regional compliance standards and interoperability, while others adopt solutions driven by access and cost considerations. In the Asia-Pacific region, rapid urbanization, expanding primary care networks, and an emphasis on decentralized testing present opportunities for simplified, rugged devices that can be deployed across clinics and remote sites.

Across these regions, distribution models and partner ecosystems vary, so commercial approaches must be adapted to local purchasing norms, reimbursement landscapes, and training capabilities. Furthermore, regional incident response protocols, workplace regulations, and law enforcement practices shape the desirability of specific device features, such as chain-of-custody enhancements, digital logging, or enhanced environmental tolerance. A regionally informed strategy that tailors product positioning, support services, and evidence packages will be crucial for converting interest into sustained adoption.

Competitive positioning anchored in assay performance, validation evidence, distribution reach, and post-market service offerings

Competitive dynamics are influenced by a combination of technological differentiation, regulatory credentials, and distribution reach. Leading companies invest in assay optimization, user-centered device design, and comprehensive validation packages to meet the distinct needs of clinical, occupational, and forensic customers. Strategic collaborations with laboratories, distributors, and observation sites support real-world performance evidence and ease the path to institutional procurement. In addition, firms that complement their product portfolios with digital enablement, customer training programs, and robust post-market surveillance differentiate on total value rather than on unit price alone.

Smaller innovators frequently drive niche breakthroughs-such as specialized analyte panels or rapid reader-assisted interpretation-while larger organizations leverage scale to offer integrated supply and service agreements. The ability to demonstrate consistent manufacturing quality, reproducible performance across batches, and responsive customer support is critical for retaining customers in settings where patient care, legal outcomes, or workplace safety are at stake. Partnerships with confirmatory laboratories and interoperability with electronic systems can further entrench a vendor's position by simplifying downstream workflows and minimizing administrative friction for buyers.

Practical and prioritized actions for manufacturers and distributors to strengthen product adaptability, supply resilience, regulatory readiness, and customer value

Industry leaders should pursue a coordinated agenda that aligns product roadmaps with operational realities and stakeholder expectations. First, prioritize modular product architectures that allow a single platform to support both multi-panel and single-panel configurations, thereby enabling faster customization for distinct end users without duplicating manufacturing complexity. Second, invest in robust validation and documentation packages tailored to clinical, forensic, and occupational use cases to streamline procurement and support regulatory compliance. Third, strengthen supply chain resilience by diversifying suppliers for critical inputs, qualifying secondary production sites, and establishing buffer inventory policies to reduce exposure to trade-related disruptions.

Fourth, expand digital capabilities that enhance result traceability, support remote oversight, and enable seamless integration with laboratory information systems and compliance platforms. Fifth, tailor commercial strategies by region, optimizing distribution partnerships and customer support models to reflect local procurement and reimbursement practices. Sixth, deepen collaborations with confirmatory laboratories and end users to generate real-world evidence and refine training materials. By executing these measures in parallel, companies can improve time-to-adoption, reduce operational risk, and preserve customer trust in environments where speed, accuracy, and chain-of-custody matter.

A transparent and reproducible methodology combining stakeholder interviews, peer-reviewed evidence, regulatory guidance, and scenario analysis to inform strategic conclusions

This research synthesizes primary and secondary inputs to construct a rigorous, reproducible view of the rapid oral fluid screening landscape. Primary engagements include structured interviews with device developers, clinical laboratory directors, occupational health managers, and law enforcement procurement leads to capture firsthand perspectives on performance priorities, procurement hurdles, and deployment experiences. Secondary sources comprise peer-reviewed literature on specimen reliability and assay performance, regulatory guidance documents, technical white papers, and publicly available product validation summaries to triangulate claims and to ensure analytical assertions are grounded in verifiable evidence.

Analytical methods involve cross-sectional comparison of device features, assessment of technology tradeoffs between chromatography and immunoassay formats, and qualitative synthesis of end-user workflows across clinical, home, forensic, and workplace contexts. Supply chain analyses consider manufacturing nodes, reagent dependencies, and trade policy implications to identify operational risk vectors. Throughout, emphasis is placed on transparency of assumptions, attribution of source material, and the use of scenario-based reasoning to surface plausible responses to trade and regulatory shifts. The methodology supports actionable conclusions while maintaining clear traceability between inputs and insights.

Concluding synthesis linking technological capability to operational imperatives and highlighting the integrated approach required to realize sustained adoption

Rapid oral fluid screening devices occupy a strategic position at the intersection of clinical need, operational practicality, and regulatory oversight. Their appeal rests on the ability to deliver timely, minimally invasive screening that supports immediate decision-making in diverse contexts. However, successful scale-up requires more than improved analytical performance; it demands alignment across validation practices, supply chain design, digital interoperability, and customer support. Organizations that adopt an integrated approach-combining robust evidence generation, regional market adaptation, and resilient logistics-will be better equipped to translate device capabilities into durable clinical and operational value.

Looking ahead, the interplay among technological innovation, regulatory evolution, and trade dynamics will continue to shape procurement behavior and product differentiation. Stakeholders who invest in modular platforms, cultivate strong confirmatory partnerships, and anticipate supply chain contingencies can reduce friction in adoption and reinforce confidence among clinical, occupational, and forensic users. In short, the pathway to meaningful impact lies in coupling device excellence with operational and commercial rigor to ensure that screening tools reliably support care, compliance, and safety objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rapid Oral Fluid Screening Devices Market, by Product Type

  • 8.1. Multi Panel
  • 8.2. Single Panel

9. Rapid Oral Fluid Screening Devices Market, by Technology

  • 9.1. Chromatography
  • 9.2. Immunoassay

10. Rapid Oral Fluid Screening Devices Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Home Testing
  • 10.3. Law Enforcement
  • 10.4. Workplace Testing

11. Rapid Oral Fluid Screening Devices Market, by End User

  • 11.1. Dedicated Drug Testing Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics

12. Rapid Oral Fluid Screening Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Rapid Oral Fluid Screening Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Rapid Oral Fluid Screening Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Rapid Oral Fluid Screening Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Rapid Oral Fluid Screening Devices Market

17. China Rapid Oral Fluid Screening Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Becton, Dickinson and Company
  • 18.7. Chembio Diagnostic Systems, Inc.
  • 18.8. Dragerwerk AG & Co. KGaA
  • 18.9. OraSure Technologies, Inc.
  • 18.10. Quidel Corporation
  • 18.11. Roche Diagnostics GmbH
  • 18.12. Securetec Detection Systems AG
  • 18.13. Siemens Healthineers AG
  • 18.14. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY MULTI PANEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY MULTI PANEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY MULTI PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY SINGLE PANEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY SINGLE PANEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY SINGLE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOME TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOME TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY LAW ENFORCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY LAW ENFORCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY LAW ENFORCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY WORKPLACE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY WORKPLACE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY WORKPLACE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DEDICATED DRUG TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DEDICATED DRUG TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DEDICATED DRUG TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA RAPID ORAL FLUID SCREENING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)